Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
"There were cold shoulders
Regional Insights North America GLP-1 Receptor Agonist Market Trends North America dominates the GLP-1 receptor agonist market with a 41.8% share in 2025 , driven by the high prevalence of diabetes and obesity, coupled with strong healthcare infrastructure and widespread insurance coverage
It is a single lab-made molecule that acts on three receptors at once: GIP, GLP-1, and glucagon
According to the American Thyroid Association, weight gain related to hypothyroidism is often modest and may be partly related to salt and water retention
Wegovy works the same way as GLP-1 in your body, which is a hormone produced in your intestines after eating
Unlike peptides that enhance general health or growth hormone, FOXO4-DRI removes harmful cells, making it a more direct approach to rejuvenation at the cellular level
US$ 24.20
US$ 27.10
